Psychiatry Research
Volume 105, Issue 1 , Pages 45-55 , 15 December 2001

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms

  • Stefania Bonaccorso

      Affiliations

    • Psychiatric Hospital, University ‘La Sapienza’, Rome, Italy
    • Department of Psychiatry, University Hospital of Maastricht, Maastricht, The Netherlands
    • Department of Psychiatry, Vanderbilt University, Nashville, TN, USA
    • ,
  • Antonella Puzella

      Affiliations

    • Psychiatric Hospital, University ‘La Sapienza’, Rome, Italy
    • ,
  • Valentina Marino

      Affiliations

    • Psychiatric Hospital, University ‘La Sapienza’, Rome, Italy
    • ,
  • Massimo Pasquini

      Affiliations

    • Psychiatric Hospital, University ‘La Sapienza’, Rome, Italy
    • ,
  • Massimo Biondi

      Affiliations

    • Psychiatric Hospital, University ‘La Sapienza’, Rome, Italy
    • ,
  • Marco Artini

      Affiliations

    • Department of Hepatology, I Medical Clinic, University ‘La Sapienza’, Rome, Italy
    • ,
  • Cristiana Almerighi

      Affiliations

    • Department of Hepatology, I Medical Clinic, University ‘La Sapienza’, Rome, Italy
    • ,
  • Massimo Levrero

      Affiliations

    • Department of Hepatology, I Medical Clinic, University ‘La Sapienza’, Rome, Italy
    • ,
  • Belinda Egyed

      Affiliations

    • Department of Psychiatry, University Hospital of Maastricht, Maastricht, The Netherlands
    • ,
  • Eugene Bosmans

      Affiliations

    • Eurogenetics, Tessenderlo, Belgium
    • ,
  • Herbert Y. Meltzer

      Affiliations

    • Department of Psychiatry, Vanderbilt University, Nashville, TN, USA
    • ,
  • Michael Maes

      Affiliations

    • Department of Psychiatry, University Hospital of Maastricht, Maastricht, The Netherlands
    • Department of Psychiatry, Vanderbilt University, Nashville, TN, USA
    • http://www.marquiswhoswho.net/mmaes/
    • Corresponding Author InformationCorresponding author. Department of Psychiatry & Neuropsychology, University Hospital of Maastricht, Postbus 5800, 6202 AZ Maastricht, The Netherlands. Tel.: +31-43-3877443; fax: +31-43-3875444

Received 30 January 2001 ,Revised 18 September 2001 ,Accepted 20 September 2001.

References 

  1. Anisman H, Kokkinidis L, Borowski T, Merali Z. Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Research. 1998;779:177–187
  2. Bluthé RM, Crestani F, Kelley KW, Dantzer R. Mechanisms of the behavioral effects of interleukin 1. Annals of the New York Academy of Sciences. 1992;650:268–275
  3. Bonaccorso S, Meltzer HY, Maes M. Psychological and behavioral effects of interferons. Current Opinion in Psychiatry. 2000;13:673–677
  4. Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., Maes, M., 2001. Major depression induced by interferon-alpha in patients affected by hepatitis C virus. Journal of Affective Disorders (in press).
  5. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alpha. Hepatology. 1996;24:6–9
  6. Cavaillon J-M. Les Cytokines. Paris: Masson; 1996;
  7. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 1998;84:923–933
  8. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology. 2000;118:346–355
  9. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alpha. Hepatology. 1999;30:526–530
  10. Fabris C, Del Forno M, Falleti E, Toniutto P, Pirisi M. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C. Clinical and Experimental Immunology. 1999;117:556–560
  11. Grungreiff K, Reinhold D, Ansorge S. Serum concentrations of sIL-2r, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Cytokines. 1999;11:1076–1080
  12. Hamilton M. The assessment of anxiety by rating. British Journal of Psychiatry. 1959;32:50–55
  13. Harraga S, Godot V, Bresson-Hadni S, Pater C, Beurton I, Bartholomot B, et al. Clinical efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon alpha2a monotherapy for human echinococcosis. Clinical Infectious Diseases. 1999;29:205–206
  14. Kamata M, Higuchi H, Yoshimoto M, Yoshida K, Shimizu T. Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentration in the rat brain. European Neuropsychopharmacology. 2000;10:129–132
  15. Kawamura C, Nakajima S, Kuroki T, Monna T. Two-dimensional analysis of production of IL-6 and TNF-alpha can predict the efficacy of IFN-alpha therapy. Hepatogastroenterology. 1999;46:2941–2945
  16. Linthorst AC, Reul JM. Brain neurotransmission during peripheral inflammation. Annals of the New York Academy of Sciences. 1998;840:139–152
  17. Maddrey WC. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed treatment-naive patients. Seminars in Liver Diseases. 1999;19:67–75
  18. Maes M, Meltzer HYM. The serotonin hypothesis of major depression. In:  Bloom F,  Kupfer D editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 933–944
  19. Maes M, Capuron L, Ravaud A, Gualde N, Bosmans E, Egyed B, et al. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology. 2001;24:130–140
  20. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Reviews. 1998;105:83–107
  21. Malaguarnera M, Di Fazio I, Laurino A, Ferlito L, Romano M, Trovato BA. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment. International Journal of Clinical Pharmacology and Therapy. 1997;35:385–388
  22. Montgomery SA, Åsberg A. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979;134:382–389
  23. Morikawa O, Sakai N, Obara H, Saito N. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. European Journal of Pharmacology. 1998;349:317–324
  24. Naveau S, Balian A, Degos F, Daurat V, Chevret S, Gayno S, et al. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha. Multicenter GER-CYT 04 Group. Journal of Hepatology. 1999;31:612–617
  25. Quiroga JA, Martin J, Pardo M, Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Digest of Diseases and Science. 1994;39:2485–2496
  26. Sakic B, Szechtman H, Braciak T, Richards C, Gauldie J, Denburg JA. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Research Bulletin. 1997;44:155–165
  27. Shimizu H, Ohtani K, Sato N, Nagamine T, Mori M. Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration. Endocrinology Journal. 1995;42:551–556
  28. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. Journal of Clinical Endocrinology and Metabolism. 1998;83:1573–1579
  29. Taylor JL, Grossberg SE. The effects of interferon-alpha on the production and action of other cytokines. Seminars in Oncology. 1998;25(1 Suppl 1):23–29
  30. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2 like T-helper cells in hepatitis C virus infection: implication for hepatitis C virus chronicity. Hepatology. 1997;25:449–458
  31. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Research. 1996;711:163–174

PII: S0165-1781(01)00315-8

Psychiatry Research
Volume 105, Issue 1 , Pages 45-55 , 15 December 2001

Article Tools

* Image Usage & Resolution